Use of an NMDA receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity

Details for Australian Patent Application No. 2005229543 (hide)

Owner Institut National de la Sante et de la Recherche Medicale (INSERM) Auris Medical AG

Inventors Puel, Jean-Luc; Pujol, Remy; Guitton, Matthieu

Agent Allens Arthur Robinson

Pub. Number AU-B-2005229543

PCT Pub. Number WO2005/094799

Priority 10/812,298 29.03.04 US

Filing date 29 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 3 December 2009

International Classifications

A61K 31/00 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4535 (2006.01)

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/094799 Priority application(s): WO2005/094799

3 December 2009 Application Accepted

  Published as AU-B-2005229543

1 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229547-Epoxy resin impregnated yarn and the use thereof for producing a preform

2005229542-Cervical intervertebral prosthesis